Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.

Reset
4335 results found

Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer

Tsang, ES; Wong, HL; Wang, Y; Renouf, DJ; Cheung, WY; Lim, HJ; Gill, S; Loree, JM; Kennecke, HF

(2019), AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 196-201

DOI: 10.1097/COC.0000000000000500

Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer

Lee, B; Lipton, L; Cohen, J; Tie, J; Javed, AA; Li, L; Goldstein, D; Burge, M; Cooray, P; Nagrial, A; Tebbutt, NC; Thomson, B; Nikfarjam, M; Harris, M; Haydon, A; Lawrence, B; Tai, DWM; Simons, K; Lennon, AM; Wolfgang, CL; Tomasetti, C; Papadopoulos, N; Kinzler, KW; Vogelstein, B; Gibbs, P

(2019), ANNALS OF ONCOLOGY, 1472-1478

DOI: 10.1093/annonc/mdz200

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

Hellmann, MD; Kim, TW; Lee, CB; Goh, BC; Miller, WH; Oh, DY; Jamal, R; Chee, CE; Chow, LQM; Gainor, JF; Desai, J; Solomon, BJ; Das Thakur, M; Pitcher, B; Foster, P; Hernandez, G; Wongchenko, MJ; Cha, E; Bang, YJ; Siu, LL; Bendell, J

(2019), ANNALS OF ONCOLOGY, 1134-1142

DOI: 10.1093/annonc/mdz113

Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial

Delaloge, S; Cella, D; Ye, Y; Buyse, M; Chan, A; Barrios, CH; Holmes, FA; Mansi, J; Iwata, H; Ejlertsen, B; Moy, B; Chia, SKL; Gnant, M; Smichkoska, S; Ciceniene, A; Martinez, N; Filipovic, S; Ben-Baruch, NE; Joy, AA; Langkjer, ST; Senecal, F; de Boer, RH; Moran, S; Yao, B; Bryce, R; Auerbach, A; Fallowfield, L; Martin, M

(2019), ANNALS OF ONCOLOGY, 567-574

DOI: 10.1093/annonc/mdz016

Whole genome and biomarker analysis of patients with recurrent glioblastoma on bevacizumab: A subset analysis of the CABARET trial

Olafson, LR; Siddell, AH; Field, KM; Byrnes, M; Rapkins, RW; Ng, B; Nixdorf, S; Barnes, EH; Johns, TG; Yip, S; Simes, J; Nowak, AK; Rosenthal, MA; McDonald, KL

(2019), JOURNAL OF CLINICAL NEUROSCIENCE, 157-163

DOI: 10.1016/j.jocn.2019.08.044

Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus

Maharaj, AD; Ioannou, L; Croagh, D; Zalcberg, J; Neale, RE; Goldstein, D; Merrett, N; Kench, JG; White, K; Pilgrim, CHC; Chantrill, L; Cosman, P; Kneebone, A; Lipton, L; Nikfarjam, M; Philip, J; Sandroussi, C; Tagkalidis, P; Chye, R; Haghighi, KS; Samra, J; Evans, SM

(2019), HPB, 444-455

DOI: 10.1016/j.hpb.2018.08.016

Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry

Ho, PJ; Moore, EM; McQuilten, ZK; Wellard, C; Bergin, K; Augustson, B; Blacklock, H; Harrison, SJ; Horvath, N; King, T; Mollee, P; Quach, H; Reid, C; Rosengarten, B; Walker, P; Wood, EM; Spencer, A

(2019), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, E415-E424

DOI: 10.1016/j.clml.2019.05.010

Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE)

Woodward, N; De Boer, RH; Redfern, A; White, M; Young, J; Truman, M; Beith, J

(2019), CLINICAL BREAST CANCER, 216-224

DOI: 10.1016/j.clbc.2019.02.008

Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival

Mendis, S; Beck, S; Lee, B; Lee, M; Wong, R; Kosmider, S; Shapiro, J; Yip, D; Steel, S; Nott, L; Jennens, R; Lipton, L; Burge, M; Field, K; Ananda, S; Wong, HL; Gibbs, P

(2019), ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 136-143

DOI: 10.1111/ajco.13135

Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia

Turner, A; McGrath, JJ; Dean, OM; Dodd, S; Baker, A; Cotton, SM; Scott, JG; Kavanagh, BE; Ashton, MM; Walker, AJ; Brown, E; Berk, M

(2019), CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 297-307

DOI: 10.9758/cpn.2019.17.2.297

Nursing home no returns policy, when residents are discharged to the emergency department at 4am: what does the law say?

Forbes, MP; Ferraro, A

(2019), MEDICAL JOURNAL OF AUSTRALIA

DOI: 10.5694/mja2.50132

Reducing risk following set-harm the need for careful prescribing

Chew-Graham, CA; Morgan, C; Webb, RT; Emery, A; Carr, MJ; Kontopantelis, E; Yung, AR; Ashcroft, DM

(2019), BRITISH JOURNAL OF GENERAL PRACTICE, 224-225

DOI: 10.3399/bjgp19X702317

Preventing and Reducing Coercive Measures-An Evaluation of the Implementation of the Safewards Model in Two Locked Wards in Germany

Baumgardt, J; Jackel, D; Helber-Bohlen, H; Stiehm, N; Morgenstern, K; Voigt, A; Schoppe, E; Mc Cutcheon, AK; Lecca, EEV; Lohr, M; Schulz, M; Bechdolf, A; Weinmann, S

(2019), FRONTIERS IN PSYCHIATRY

DOI: 10.3389/fpsyt.2019.00340

The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia

Ashton, MM; Dean, OM; Walker, AJ; Bortolasci, CC; Ng, CH; Hopwood, M; Harvey, BH; Moller, M; McGrath, JJ; Marx, W; Turner, A; Dodd, S; Scott, JG; Khoo, JP; Walder, K; Sarris, J; Berk, M

(2019), FRONTIERS IN PSYCHIATRY

DOI: 10.3389/fpsyt.2019.00115

Collaborative Efforts for Understanding the Human Brain

Liew, SL; Schmaal, L; Jahanshad, N

(2019), FRONTIERS IN NEUROINFORMATICS

DOI: 10.3389/fninf.2019.00038

Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial

Ashton, MM; Berk, M; Ng, CH; Hopwood, M; Dodd, S; Turner, A; Brown, E; Jacka, FN; Cotton, SM; Khoo, JP; Chatterton, ML; Kavanagh, BE; Nadjidai, SE; Lo Monaco, SL; Harvey, BH; Sarris, J; Malhi, GS; Dowling, NL; Dean, OM

(2019), BRAZILIAN JOURNAL OF PSYCHIATRY, 245-253

DOI: 10.1590/1516-4446-2018-0114

Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition

Hidalgo-Mazzei, D; Berk, M; Cipriani, A; Cleare, AJ; Di Florio, A; Dietch, D; Geddes, JR; Goodwin, GM; Grunze, H; Hayes, JF; Jones, I; Kasper, S; Macritchie, K; McAllister-Williams, RH; Morriss, R; Nayrouz, S; Pappa, S; Soares, JC; Smith, DJ; Suppes, T; Talbot, P; Vieta, E; Watson, S; Yatham, LN; Young, AH; Stokes, PRA

(2019), BRITISH JOURNAL OF PSYCHIATRY, 27-35

DOI: 10.1192/bjp.2018.257

An online intervention for improving stroke survivors' health-related quality of life: study protocol for a randomised controlled trial

Guillaumier, A; McCrabb, S; Spratt, NJ; Pollack, M; Baker, AL; Magin, P; Turner, A; Oldmeadow, C; Collins, C; Callister, R; Levi, C; Searles, A; Deeming, S; Wynne, O; Denham, AMJ; Clancy, B; Bonevski, B

(2019), TRIALS

DOI: 10.1186/s13063-019-3604-0

Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosis

Lim, C; Baker, A; Saha, S; Foley, S; Gordon, A; Ward, D; Burgher, B; Dark, F; Beckmann, M; Stathis, S; Bruxner, G; Ryan, A; Richardson, D; Hatherill, S; Berk, M; Dean, O; McGrath, J; Scott, J

(2019), TRIALS

DOI: 10.1186/s13063-019-3232-8

Mapping Cancer incidence across Western Victoria: the association with age, accessibility, and socioeconomic status among men and women

Cowdery, SP; Sajjad, MA; Holloway-Kew, KL; Mohebbi, M; Williams, LJ; Kotowicz, MA; Livingston, PM; Khasraw, M; Hakkennes, S; Dunning, TL; Brumby, S; Page, RS; Sutherland, AG; Brennan-Olsen, SL; Berk, M; Campbell, D; Pasco, JA

(2019), BMC CANCER

DOI: 10.1186/s12885-019-6070-x

The impact of substance use on treatment as a compulsory patient

Vine, R; Tibble, H; Pirkis, J; Spittal, M; Judd, F

(2019), AUSTRALASIAN PSYCHIATRY, 378-382

DOI: 10.1177/1039856219852286

A sense of dread: affect and risk perception in people with schizophrenia during an influenza pandemic

Maguire, PA; Reay, RE; Looi, JCL

(2019), AUSTRALASIAN PSYCHIATRY, 450-455

DOI: 10.1177/1039856219839467

Nothing to sneeze at - uptake of protective measures against an influenza pandemic by people with schizophrenia: willingness and perceived barriers

Maguire, PA; Reay, RE; Looi, JCL

(2019), AUSTRALASIAN PSYCHIATRY, 171-178

DOI: 10.1177/1039856218815748

Faecal microbiota transplants for depression - Who gives a crapsule?

Green, J; Castle, D; Berk, M; Hair, C; Loughman, A; Cryan, J; Nierenberg, A; Athan, E; Jacka, F

(2019), AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 732-734

DOI: 10.1177/0004867419839776

Does legislative change affect the use and duration of compulsory treatment orders?

Vine, R; Tibble, H; Pirkis, J; Judd, F; Spittal, MJ

(2019), AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 433-440

DOI: 10.1177/0004867418812683

Support for Carers of Young People with Mental Illness: Design and Trial of a Technology-Mediated Therapy

Lederman, R; Gleeson, J; Wadley, G; D'Alfonso, S; Rice, S; Santesteban-Echarri, O; Alvarez-Jimenez, M

(2019), ACM TRANSACTIONS ON COMPUTER-HUMAN INTERACTION

DOI: 10.1145/3301421

Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: protocol for a systematic review

Ashton, MM; Berk, M; Ng, CH; Hopwood, M; Kavanagh, B; Williams, LJ; Sarris, J; Dean, OM

(2019), BMJ OPEN

DOI: 10.1136/bmjopen-2018-025640

Protocol for a prospective, longitudinal mixed-methods case study: supporting a Model of Care for Healthier Adolescents (The MoCHA study)

Hayes, C; Palmer, VJ; Simmons, M; Hamilton, B; Simons, C; Hopwood, M

(2019), BMJ OPEN

DOI: 10.1136/bmjopen-2018-025098

An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder

Faedda, GL; Baldessarini, RJ; Marangoni, C; Bechdolf, A; Berk, M; Birmaher, B; Conus, P; DelBello, MP; Duffy, AC; Hillegers, MHJ; Pfennig, A; Post, RM; Preisig, M; Ratheesh, A; Salvatore, P; Tohen, M; Vazquez, GH; Vieta, E; Yatham, LN; Youngstrom, EA; Van Meter, A; Correll, CU

(2019), BIPOLAR DISORDERS, 720-740

DOI: 10.1111/bdi.12831

Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder

Dodd, S; Walker, AJ; Brnabic, AJM; Hong, N; Burns, A; Berk, M

(2019), BIPOLAR DISORDERS, 142-150

DOI: 10.1111/bdi.12662

78 79 80 81 82 83 84 85 86